Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

A review of 65 years of human adenovirus seroprevalence.

Mennechet FJD, Paris O, Ouoba AR, Salazar Arenas S, Sirima SB, Takoudjou Dzomo GR, Diarra A, Traore IT, Kania D, Eichholz K, Weaver EA, Tuaillon E, Kremer EJ.

Expert Rev Vaccines. 2019 Jun;18(6):597-613. doi: 10.1080/14760584.2019.1588113. Epub 2019 May 27.

PMID:
31132024
2.

CAV-2 Vector Development and Gene Transfer in the Central and Peripheral Nervous Systems.

Del Rio D, Beucher B, Lavigne M, Wehbi A, Gonzalez Dopeso-Reyes I, Saggio I, Kremer EJ.

Front Mol Neurosci. 2019 Mar 29;12:71. doi: 10.3389/fnmol.2019.00071. eCollection 2019. Review.

3.

Combining Gene Transfer and Nonhuman Primates to Better Understand and Treat Parkinson's Disease.

Lasbleiz C, Mestre-Francés N, Devau G, Luquin MR, Tenenbaum L, Kremer EJ, Verdier JM.

Front Mol Neurosci. 2019 Feb 11;12:10. doi: 10.3389/fnmol.2019.00010. eCollection 2019.

4.

Lysosomal and network alterations in human mucopolysaccharidosis type VII iPSC-derived neurons.

Bayó-Puxan N, Terrasso AP, Creyssels S, Simão D, Begon-Pescia C, Lavigne M, Salinas S, Bernex F, Bosch A, Kalatzis V, Levade T, Cuervo AM, Lory P, Consiglio A, Brito C, Kremer EJ.

Sci Rep. 2018 Nov 9;8(1):16644. doi: 10.1038/s41598-018-34523-3.

5.

Humoral immune response to adenovirus induce tolerogenic bystander dendritic cells that promote generation of regulatory T cells.

Tran TTP, Eichholz K, Amelio P, Moyer C, Nemerow GR, Perreau M, Mennechet FJD, Kremer EJ.

PLoS Pathog. 2018 Aug 20;14(8):e1007127. doi: 10.1371/journal.ppat.1007127. eCollection 2018 Aug.

6.

Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate.

Mestre-Francés N, Serratrice N, Gennetier A, Devau G, Cobo S, Trouche SG, Fontès P, Zussy C, De Deurwaerdere P, Salinas S, Mennechet FJ, Dusonchet J, Schneider BL, Saggio I, Kalatzis V, Luquin-Piudo MR, Verdier JM, Kremer EJ.

JCI Insight. 2018 Jul 26;3(14). pii: 98202. doi: 10.1172/jci.insight.98202. eCollection 2018 Jul 26.

7.

Thalamocortical and corticothalamic pathways differentially contribute to goal-directed behaviors in the rat.

Alcaraz F, Fresno V, Marchand AR, Kremer EJ, Coutureau E, Wolff M.

Elife. 2018 Feb 6;7. pii: e32517. doi: 10.7554/eLife.32517.

8.
9.

[Anti-adenovirus humoral immunity: impact on dendritic cell activation].

Mennechet FJD, Eichholz K, Tran TTP, Kremer EJ.

Med Sci (Paris). 2017 Jun-Jul;33(6-7):582-585. doi: 10.1051/medsci/20173306008. Epub 2017 Jul 19. French. No abstract available.

10.

Modular organization of the brainstem noradrenaline system coordinates opposing learning states.

Uematsu A, Tan BZ, Ycu EA, Cuevas JS, Koivumaa J, Junyent F, Kremer EJ, Witten IB, Deisseroth K, Johansen JP.

Nat Neurosci. 2017 Nov;20(11):1602-1611. doi: 10.1038/nn.4642. Epub 2017 Sep 18.

PMID:
28920933
11.

What is CAR doing in the middle of the adult neurogenic road?

Salinas S, Junyent F, Coré N, Cremer H, Kremer EJ.

Neurogenesis (Austin). 2017 Apr 27;4(1):e1304790. doi: 10.1080/23262133.2017.1304790. eCollection 2017.

12.

[The coxsackievirus and adenovirus receptor is involved in cognitive processes].

Zussy C, Loustalot F, Junyent F, Kremer EJ, Salinas S.

Med Sci (Paris). 2017 Jan;33(1):89-92. doi: 10.1051/medsci/20173301016. Epub 2017 Jan 25. French. No abstract available.

13.

Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells.

Eichholz K, Bru T, Tran TT, Fernandes P, Welles H, Mennechet FJ, Manel N, Alves P, Perreau M, Kremer EJ.

PLoS Pathog. 2016 Sep 16;12(9):e1005871. doi: 10.1371/journal.ppat.1005871. eCollection 2016 Sep.

14.

Coxsackievirus Adenovirus Receptor Loss Impairs Adult Neurogenesis, Synapse Content, and Hippocampus Plasticity.

Zussy C, Loustalot F, Junyent F, Gardoni F, Bories C, Valero J, Desarménien MG, Bernex F, Henaff D, Bayo-Puxan N, Chen JW, Lonjon N, de Koninck Y, Malva JO, Bergelson JM, di Luca M, Schiavo G, Salinas S, Kremer EJ.

J Neurosci. 2016 Sep 14;36(37):9558-71. doi: 10.1523/JNEUROSCI.0132-16.2016.

15.

Membrane Dynamics and Signaling of the Coxsackievirus and Adenovirus Receptor.

Loustalot F, Kremer EJ, Salinas S.

Int Rev Cell Mol Biol. 2016;322:331-62. doi: 10.1016/bs.ircmb.2015.10.006. Epub 2015 Dec 23.

PMID:
26940522
16.

Retrograde optogenetic characterization of the pontospinal module of the locus coeruleus with a canine adenoviral vector.

Li Y, Hickey L, Perrins R, Werlen E, Patel AA, Hirschberg S, Jones MW, Salinas S, Kremer EJ, Pickering AE.

Brain Res. 2016 Jun 15;1641(Pt B):274-90. doi: 10.1016/j.brainres.2016.02.023. Epub 2016 Feb 19.

17.

[Is there a risk of zoonotic disease due to adenoviruses?].

Loustalot F, Creyssels S, Salinas S, Benkõ M, Harrach B, Mennechet FJ, Kremer EJ.

Med Sci (Paris). 2015 Dec;31(12):1102-8. doi: 10.1051/medsci/20153112013. Epub 2015 Dec 16. Review. French.

18.

Ebola virus vaccine: benefit and risks of adenovirus-based vectors.

Mennechet FJ, Tran TT, Eichholz K, van de Perre P, Kremer EJ.

Expert Rev Vaccines. 2015;14(11):1471-8. doi: 10.1586/14760584.2015.1083429. Epub 2015 Aug 31. Review.

PMID:
26325242
19.

CAV-2--why a canine virus is a neurobiologist's best friend.

Junyent F, Kremer EJ.

Curr Opin Pharmacol. 2015 Oct;24:86-93. doi: 10.1016/j.coph.2015.08.004. Epub 2015 Aug 25. Review.

PMID:
26298516
20.

Circuit Architecture of VTA Dopamine Neurons Revealed by Systematic Input-Output Mapping.

Beier KT, Steinberg EE, DeLoach KE, Xie S, Miyamichi K, Schwarz L, Gao XJ, Kremer EJ, Malenka RC, Luo L.

Cell. 2015 Jul 30;162(3):622-34. doi: 10.1016/j.cell.2015.07.015.

21.

Transcriptional Response of Human Neurospheres to Helper-Dependent CAV-2 Vectors Involves the Modulation of DNA Damage Response, Microtubule and Centromere Gene Groups.

Piersanti S, Burla R, Licursi V, Brito C, La Torre M, Alves PM, Simao D, Mottini C, Salinas S, Negri R, Tagliafico E, Kremer EJ, Saggio I.

PLoS One. 2015 Jul 24;10(7):e0133607. doi: 10.1371/journal.pone.0133607. eCollection 2015.

22.

Evaluation of helper-dependent canine adenovirus vectors in a 3D human CNS model.

Simão D, Pinto C, Fernandes P, Peddie CJ, Piersanti S, Collinson LM, Salinas S, Saggio I, Schiavo G, Kremer EJ, Brito C, Alves PM.

Gene Ther. 2016 Jan;23(1):86-94. doi: 10.1038/gt.2015.75. Epub 2015 Aug 20.

23.

The Intracellular Domain of the Coxsackievirus and Adenovirus Receptor Differentially Influences Adenovirus Entry.

Loustalot F, Kremer EJ, Salinas S.

J Virol. 2015 Sep;89(18):9417-26. doi: 10.1128/JVI.01488-15. Epub 2015 Jul 1.

24.

Viral-genetic tracing of the input-output organization of a central noradrenaline circuit.

Schwarz LA, Miyamichi K, Gao XJ, Beier KT, Weissbourd B, DeLoach KE, Ren J, Ibanes S, Malenka RC, Kremer EJ, Luo L.

Nature. 2015 Aug 6;524(7563):88-92. doi: 10.1038/nature14600. Epub 2015 Jul 1.

25.

Adenovirus tales: from the cell surface to the nuclear pore complex.

Kremer EJ, Nemerow GR.

PLoS Pathog. 2015 Jun 4;11(6):e1004821. doi: 10.1371/journal.ppat.1004821. eCollection 2015 Jun. Review. No abstract available.

26.

Canine helper-dependent vectors production: implications of Cre activity and co-infection on adenovirus propagation.

Fernandes P, Almeida AI, Kremer EJ, Alves PM, Coroadinha AS.

Sci Rep. 2015 Mar 16;5:9135. doi: 10.1038/srep09135.

27.

Ebola vaccines based on adenovirus vectors and risk of HIV.

Kremer EJ, Van de Perre P.

BMJ. 2015 Mar 10;350:h1307. doi: 10.1136/bmj.h1307. No abstract available.

PMID:
25757599
28.

Human coagulation factor X-adenovirus type 5 complexes poorly stimulate an innate immune response in human mononuclear phagocytes.

Eichholz K, Mennechet FJ, Kremer EJ.

J Virol. 2015 Mar;89(5):2884-91. doi: 10.1128/JVI.03576-14. Epub 2014 Dec 24.

29.

Impact of adenovirus life cycle progression on the generation of canine helper-dependent vectors.

Fernandes P, Simão D, Guerreiro MR, Kremer EJ, Coroadinha AS, Alves PM.

Gene Ther. 2015 Jan;22(1):40-9. doi: 10.1038/gt.2014.92. Epub 2014 Oct 23.

PMID:
25338917
30.

Modeling human neural functionality in vitro: three-dimensional culture for dopaminergic differentiation.

Simão D, Pinto C, Piersanti S, Weston A, Peddie CJ, Bastos AE, Licursi V, Schwarz SC, Collinson LM, Salinas S, Serra M, Teixeira AP, Saggio I, Lima PA, Kremer EJ, Schiavo G, Brito C, Alves PM.

Tissue Eng Part A. 2015 Feb;21(3-4):654-68. doi: 10.1089/ten.TEA.2014.0079. Epub 2014 Nov 11.

PMID:
25257211
31.

Do nonhuman primate or bat adenoviruses pose a risk for human health?

Benkő M, Harrach B, Kremer EJ.

Future Microbiol. 2014;9(3):269-72. doi: 10.2217/fmb.13.170. No abstract available.

PMID:
24762301
32.

Corrective GUSB transfer to the canine mucopolysaccharidosis VII cornea using a helper-dependent canine adenovirus vector.

Serratrice N, Cubizolle A, Ibanes S, Mestre-Francés N, Bayo-Puxan N, Creyssels S, Gennetier A, Bernex F, Verdier JM, Haskins ME, Couderc G, Malecaze F, Kalatzis V, Kremer EJ.

J Control Release. 2014 May 10;181:22-31. doi: 10.1016/j.jconrel.2014.02.022. Epub 2014 Mar 4.

33.

Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain.

Cubizolle A, Serratrice N, Skander N, Colle MA, Ibanes S, Gennetier A, Bayo-Puxan N, Mazouni K, Mennechet F, Joussemet B, Cherel Y, Lajat Y, Vite C, Bernex F, Kalatzis V, Haskins ME, Kremer EJ.

Mol Ther. 2014 Apr;22(4):762-73. doi: 10.1038/mt.2013.283. Epub 2013 Dec 17.

34.

Central nervous system delivery of helper-dependent canine adenovirus corrects neuropathology and behavior in mucopolysaccharidosis type VII mice.

Ariza L, Giménez-Llort L, Cubizolle A, Pagès G, García-Lareu B, Serratrice N, Cots D, Thwaite R, Chillón M, Kremer EJ, Bosch A.

Hum Gene Ther. 2014 Mar;25(3):199-211. doi: 10.1089/hum.2013.152. Epub 2014 Jan 23.

35.

Disruption of the coxsackievirus and adenovirus receptor-homodimeric interaction triggers lipid microdomain- and dynamin-dependent endocytosis and lysosomal targeting.

Salinas S, Zussy C, Loustalot F, Henaff D, Menendez G, Morton PE, Parsons M, Schiavo G, Kremer EJ.

J Biol Chem. 2014 Jan 10;289(2):680-95. doi: 10.1074/jbc.M113.518365. Epub 2013 Nov 22.

36.

Canine adenovirus type 2 vector generation via I-Sce1-mediated intracellular genome release.

Ibanes S, Kremer EJ.

PLoS One. 2013 Aug 1;8(8):e71032. doi: 10.1371/journal.pone.0071032. Print 2013.

37.

Differentiated neuroprogenitor cells incubated with human or canine adenovirus, or lentiviral vectors have distinct transcriptome profiles.

Piersanti S, Astrologo L, Licursi V, Costa R, Roncaglia E, Gennetier A, Ibanes S, Chillon M, Negri R, Tagliafico E, Kremer EJ, Saggio I.

PLoS One. 2013 Jul 26;8(7):e69808. doi: 10.1371/journal.pone.0069808. Print 2013.

38.

Combined antiapoptotic and antioxidant approach to acute neuroprotection for stroke in hypertensive rats.

Ord EN, Shirley R, McClure JD, McCabe C, Kremer EJ, Macrae IM, Work LM.

J Cereb Blood Flow Metab. 2013 Aug;33(8):1215-24. doi: 10.1038/jcbfm.2013.70. Epub 2013 May 1.

39.

Impact of E1 and Cre on adenovirus vector amplification: developing MDCK CAV-2-E1 and E1-Cre transcomplementing cell lines.

Fernandes P, Santiago VM, Rodrigues AF, Tomás H, Kremer EJ, Alves PM, Coroadinha AS.

PLoS One. 2013;8(4):e60342. doi: 10.1371/journal.pone.0060342. Epub 2013 Apr 2.

40.

Adenoviruses - from pathogens to therapeutics: a report on the 10th International Adenovirus Meeting.

Greber UF, Arnberg N, Wadell G, Benkő M, Kremer EJ.

Cell Microbiol. 2013 Jan;15(1):16-23. doi: 10.1111/cmi.12031. Epub 2012 Oct 11. No abstract available.

PMID:
22985121
41.

Bioprocess development for canine adenovirus type 2 vectors.

Fernandes P, Peixoto C, Santiago VM, Kremer EJ, Coroadinha AS, Alves PM.

Gene Ther. 2013 Apr;20(4):353-60. doi: 10.1038/gt.2012.52. Epub 2012 Jul 5.

PMID:
22763405
42.

Corneal transduction by intra-stromal injection of AAV vectors in vivo in the mouse and ex vivo in human explants.

Hippert C, Ibanes S, Serratrice N, Court F, Malecaze F, Kremer EJ, Kalatzis V.

PLoS One. 2012;7(4):e35318. doi: 10.1371/journal.pone.0035318. Epub 2012 Apr 16.

43.

A Siglec-like sialic-acid-binding motif revealed in an adenovirus capsid protein.

Rademacher C, Bru T, McBride R, Robison E, Nycholat CM, Kremer EJ, Paulson JC.

Glycobiology. 2012 Aug;22(8):1086-91. doi: 10.1093/glycob/cws073. Epub 2012 Apr 21.

44.

The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes.

Perreau M, Welles HC, Pellaton C, Gjoksi B, Potin L, Martin R, Harari A, Bett A, Casimiro D, Gall J, Barouch DH, Kremer EJ, Pantaleo G.

J Virol. 2012 Jun;86(11):6279-85. doi: 10.1128/JVI.00123-12. Epub 2012 Apr 4.

45.

3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].

Brito C, Simão D, Costa I, Malpique R, Pereira CI, Fernandes P, Serra M, Schwarz SC, Schwarz J, Kremer EJ, Alves PM.

Methods. 2012 Mar;56(3):452-60. doi: 10.1016/j.ymeth.2012.03.005. Epub 2012 Mar 14. Erratum in: Methods. 2012 May;57(1):138.

PMID:
22433395
46.

Virus induced and associated post-translational modifications.

Salinas S, Kremer EJ.

Biol Cell. 2012 Mar;104(3):119-20. doi: 10.1111/boc.201290008. No abstract available.

PMID:
22380478
47.

An update on canine adenovirus type 2 and its vectors.

Bru T, Salinas S, Kremer EJ.

Viruses. 2010 Sep;2(9):2134-53. doi: 10.3390/v2092134. Epub 2010 Sep 27.

48.

Helper-dependent canine adenovirus vector-mediated transgene expression in a neurodegenerative lysosomal storage disorder.

Lau AA, Rozaklis T, Ibanes S, Luck AJ, Beard H, Hassiotis S, Mazouni K, Hopwood JJ, Kremer EJ, Hemsley KM.

Gene. 2012 Jan 1;491(1):53-7. doi: 10.1016/j.gene.2011.09.004. Epub 2011 Sep 22.

PMID:
21963444
49.

DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.

Perreau M, Welles HC, Harari A, Hall O, Martin R, Maillard M, Dorta G, Bart PA, Kremer EJ, Tartaglia J, Wagner R, Esteban M, Levy Y, Pantaleo G.

J Virol. 2011 Oct;85(19):9854-62. doi: 10.1128/JVI.00788-11. Epub 2011 Jul 20.

50.

An adenovirus traffic update: from receptor engagement to the nuclear pore.

Henaff D, Salinas S, Kremer EJ.

Future Microbiol. 2011 Feb;6(2):179-92. doi: 10.2217/fmb.10.162. Review.

PMID:
21366418

Supplemental Content

Loading ...
Support Center